Shin Nippon Biomedical Laboratories, Ltd. → Wave Life Sciences Ltd. WVE

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

6 13D/G filings on this issuer

5 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-03-31

DTC 1.50

13,210,972 shares short · -1.5% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $3K

Duquesne Family Office

Other 13D/G Filings on Wave Life Sciences Ltd.

Filed	Form	Filer	Stake	Shares
2024-10-01	SC	RA CAPITAL MANAGEMENT, L.P.	—	—	view →
2022-07-20	SC	Kagoshima Shinsangyo Sousei Investment Limited Partnership	—	—	view →
2019-01-28	SC	RA CAPITAL MANAGEMENT, LLC	—	—	view →
2018-04-26	SC	Shin Nippon Biomedical Laboratories, Ltd.	—	—	view →
2018-03-22	SC	Kagoshima Shinsangyo Sousei Investment Limited Partnership	—	—	view →

Other Filings by Shin Nippon Biomedical Laboratories, Ltd.

Filed	Form	Issuer	Stake	Shares
2018-04-26	SC	Wave Life Sciences Ltd. WVE	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →